Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Lovell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
British Journal of Sports Medicine|May 23, 2007
A continuous mental task decreases the physiological response to soccer-specific intermittent exerciseMatt Greig, David Marchant, Richard Lovell, et al.
Hematology Reports|March 28, 2019
A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplantClaire Horgan, Alexandros Kanellopoulos, Shankara Paneesha, et al.
Acta Haematologica|November 27, 2004
Performing bone marrow harvest on an outpatient basis: a single center UK experienceAamer Aleem, Richard Lovell, Kathy Holder, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|December 5, 2018
Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrowZbigniew Rudzki, Richard Lovell, Ben Miller, et al.
Hematology Reports|April 9, 2014
Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasmAnand Lokare, Emmanouil Nikolousis, Neil Phillips, et al.
Annals of Hematology|June 15, 2010
Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignanciesEmmanouil Nikolousis, Sandeep Nagra, Shankara Paneesha, et al.
British Journal of Haematology|August 16, 2005
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survivalRichard Lovell, Janet A Dunn, Gulnaz Begum, et al.
Leukemia & Lymphoma|December 3, 2005
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chainsGuy Pratt, Graham P Mead, Keith R Godfrey, et al.
European Journal of Haematology|June 21, 2017
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplantKate Randall, Maria Kaparou, Evgenia Xenou, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
British Journal of Sports Medicine|May 23, 2007
A continuous mental task decreases the physiological response to soccer-specific intermittent exerciseMatt Greig, David Marchant, Richard Lovell, et al.
Hematology Reports|March 28, 2019
A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplantClaire Horgan, Alexandros Kanellopoulos, Shankara Paneesha, et al.
Acta Haematologica|November 27, 2004
Performing bone marrow harvest on an outpatient basis: a single center UK experienceAamer Aleem, Richard Lovell, Kathy Holder, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|December 5, 2018
Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrowZbigniew Rudzki, Richard Lovell, Ben Miller, et al.
Hematology Reports|April 9, 2014
Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasmAnand Lokare, Emmanouil Nikolousis, Neil Phillips, et al.
Annals of Hematology|June 15, 2010
Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignanciesEmmanouil Nikolousis, Sandeep Nagra, Shankara Paneesha, et al.
British Journal of Haematology|August 16, 2005
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survivalRichard Lovell, Janet A Dunn, Gulnaz Begum, et al.
Leukemia & Lymphoma|December 3, 2005
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chainsGuy Pratt, Graham P Mead, Keith R Godfrey, et al.
European Journal of Haematology|June 21, 2017
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplantKate Randall, Maria Kaparou, Evgenia Xenou, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
Pageof 2